mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.01 |
mRNA |
Erlotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.02 |
mRNA |
BRD-K96970199 |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
0.02 |
mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.02 |
mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.02 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.02 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.02 |
mRNA |
niclosamide |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.02 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.02 |
mRNA |
TAE684 |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.02 |